KEROS THERAPEUTICS, INC.

Profile

Company Names

KEROS THERAPEUTICS, INC.

Addresses

99 HAYDEN AVENUE, BUILDING E, SUITE 120, LEXINGTON, MA 02421

99 HAYDEN AVENUE, SUITE 120 (BLD E), LEDGEMONT TECHNOLOGY CENTER, LEXINGTON, MA 02421

3 LINCOLN TERRACE, LEXINGTON, MA 02421

Phone Numbers

617-513-8774

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$78,500,054.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-03-02 
$56,000,057.00 
$56,000,057.00 
$0.00 
Equity 
2
2018-11-09 
$11,499,997.00 
$22,999,928.00 
$11,499,931.00 
Equity 
1
2016-04-15 
$11,000,000.00 
$11,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ZAFRIRA 
 
AVNUR 
DIRECTOR
MICROBION CORP   |  BIOARRAY GENETICS, INC.   |  KEROS THERAPEUTICS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  VARIANTYX INC.
NIMA 
 
FARZAN 
DIRECTOR
KEROS THERAPEUTICS, INC.   |  LATIGO BIOTHERAPEUTICS, INC.
CARL 
 
GORDON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  AMNIS CORP   |  IGENICA INC   |  ACCELERON PHARMA INC   |  ARAGON PHARMACEUTICALS, INC.   |  GOOD START GENETICS, INC.   |  ARSANIS, INC.   |  SINGULEX INC   |  SELECTA BIOSCIENCES INC   |  IGENICA BIOTHERAPEUTICS, INC   |  COMPASS THERAPEUTICS LLC   |  ADICET BIO, INC.   |  INTELLIA THERAPEUTICS, INC.   |  ALECTOR LLC   |  GEMINI THERAPEUTICS, INC.   |  SPRINGWORKS THERAPEUTICS, LLC   |  PREVAIL THERAPEUTICS INC.   |  THESEUS PHARMACEUTICALS, INC.   |  TP THERAPEUTICS, INC.   |  KUMQUAT BIOSCIENCES INC   |  PASSAGE BIO, INC.   |  KEROS THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  BLOSSOMHILL THERAPEUTICS, INC.   |  SCRIBE THERAPEUTICS, INC.   |  GARUDA THERAPEUTICS, INC.   |  ODYSSEY THERAPEUTICS, INC.   |  ALTEROME THERAPEUTICS, INC.   |  AVENZO THERAPEUTICS, INC.   |  MBX BIOSCIENCES, INC.   |  ARRIVENT BIOPHARMA, INC.   |  BELENOS BIOSCIENCES, INC.   |  LOMOND THERAPEUTICS HOLDINGS, INC.   |  STAR THERAPEUTICS LLC
OHAD 
 
HAMMER 
DIRECTOR
KEROS THERAPEUTICS, INC.
JULIUS 
 
KNOWLES 
DIRECTOR
KEROS THERAPEUTICS, INC.   |  TILOS THERAPEUTICS, INC.   |  PARTNERS INNOVATION FUND II, L.P.   |  ABCURO, INC.   |  PROXIMITY THERAPEUTICS, INC.   |  65 THERAPEUTICS, INC.   |  20 BIO, INC.
JENN 
 
LACHEY 
EXECUTIVE OFFICER
KEROS THERAPEUTICS, INC.
ALON 
 
LAZARUS 
DIRECTOR
KEROS THERAPEUTICS, INC.   |  ONCORUS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  AURON THERAPEUTICS, INC.   |  BLUEJAY THERAPEUTICS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  ENTACT BIO, INC.   |  REUNION NEUROSCIENCE, INC.   |  CROSSBOW THERAPEUTICS, INC.
RAN 
 
NUSSBAUM 
DIRECTOR
KITE PHARMA, INC.   |  KEROS THERAPEUTICS, INC.   |  UROGEN PHARMA LTD.   |  LB PHARMACEUTICALS INC   |  GRAVITON BIOSCIENCE CORP
CLAUDIA 
 
ORDONEZ 
EXECUTIVE OFFICER
KEROS THERAPEUTICS, INC.
KEITH 
 
REGNANTE 
EXECUTIVE OFFICER
KEROS THERAPEUTICS, INC.
JASBIR 
 
SEEHRA 
EXECUTIVE OFFICER, DIRECTOR
ACCELERON PHARMA INC   |  KEROS THERAPEUTICS, INC.
JASBIR 
S. 
SEEHRA 
EXECUTIVE OFFICER, DIRECTOR
KEROS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-03-12
D
Link
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-03-02 
2018-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2017-11-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-15 
2016-08-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-15 
2016-04-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#